Adherence to Medication Regimen in Patients with Severe and Chronic Psychiatric Disorders: A Qualitative Study

REFERENCES

• Barkhof, E., Meijer, C. J., de Sonneville, L. M. J., Linszen, D. H, & de Haan, L. (2012). Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade. European Psychiatry, 27, 9–18.
   PubMed Web of Science ®Google Scholar
• Bowersox, N. W. (December, 2010). Treatment attrition and relapse readmission in psychiatric inpatients: Predictors of treatment engagement and psychiatric relapse. Milwaukee, WI: Marquette University.
   Google Scholar
• Byerly, M., Fisher, R., Whatley, K., Holland, R., Varghese, F., Carmody, T, … Rush, A. J. (2005). A comparison of electronic monitoring vs clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Research, 133(2–3), 129–133.
   PubMed Web of Science ®Google Scholar
• Chen, E. Y. H., Hui, C. L. M., Dunn, E. L. W., Miao, M. Y. K., Yeung, W. S., Wong, C. K., … Tang, W. N. (2005). A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients. Schizophrenia Research, 77(1), 99–104.
   PubMed Web of Science ®Google Scholar
• Elo, S., & Kyngas, H. (2008). The qualitative content analysis process. Journal of Advanced Nursing, 62(1), 107–115.
   PubMed Web of Science ®Google Scholar
• Fialko, L., Garety, P. A., Kuipers, E., Dunn, G., Bebbington, P. E., Fowler, D., & Freeman, D. (2008). A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophrenia Research, 100(1–3), 53–59.
   PubMed Web of Science ®Google Scholar
• Gaebel, W., Schreiner, A., Bergmans, P., de Arce, R., Rouillon, F., Cordes, J., … Smeraldi, E. (2010). Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial. Neuropsychopharmacology, 35(12), 2367–2377. doi:10.1038/npp.2010.111
   PubMed Web of Science ®Google Scholar
• Graneheim, U. H., & Lundman, B. (2004). Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Education Today, 24, 105–112.
   PubMed Web of Science ®Google Scholar
• Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions for enhancing medication adherence (Review): The Cochrane Collaboration. Cochrane Database of Systematic Reviews, 2008 April 16(2), CD000011. doi: 10.1002/14651858.CD000011.pub3.
   Google Scholar
• Hudson, T. J., Owen, R R., Thrush, C. R., Armitage, T. L., & Thapa, P. (2008). Guideline implementation and patient tailoring strategies to improve medication adherence for schizophrenia. Journal of Clinical Psychiatry, 69(1), 74–80.
   PubMed Web of Science ®Google Scholar
• Hudson, T. J., Owen, R. R., Thrush, C. R., Han, X., Pyne, J. M., Thapa, P., & Sullivan, G. (2004). A pilot study of barriers to medication adherence in schizophrenia. Journal of Clinical Psychiatry, 65(2), 211–216.
   PubMed Web of Science ®Google Scholar
• Kampman, O., Laippala, P., Vaananen, J., Koivisto, E., Kiviniemi, P., Kilkku, N., & Lehtinen, K. (2002). Indicators of medication compliance in first-episode psychosis. Psychiatry Research, 110(1), 39–48.
   PubMed Web of Science ®Google Scholar
• Kane, J. M., Kishimoto, T., & Correll, C. U. (2013). Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry, 12(3), 216–226.
   PubMed Web of Science ®Google Scholar
• Keck, P., McElroy, B., & Strakowski, S. (1998). Factors associated with pharmacologic non-compliance in patients with mania. Journal of Clinical Psychology, 57, 292–297.
   Web of Science ®Google Scholar
• Kikkert, M. J., Schene, A. H., Koeter, M. W., Robson, D., Born, A., Helm, H., … Gray, R. J. (2006). Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophrenia Bulletin, 32(4), 786–794. doi: 10.1093/schbul/sbl011
   PubMed Web of Science ®Google Scholar
• Klingberg, S., Schneider, S., Wittorf, A., Buchkremer, G., & Wiedemann, G. (2008). Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors. Psychiatry Research, 8161(2), 225–234.
   Web of Science ®Google Scholar
• Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002). Prevalence of and risk factors for medication non-adherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychology, 63(10), 892–909.
   Web of Science ®Google Scholar
• Lang, K., Meyers, J. L., Korn, J. R., Pharm, S. L., Pharm, M. S., Crivera, C., … Menzin, J. (2010). Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatric Services, 61(12), 1239–1247.
   PubMed Web of Science ®Google Scholar
• Lehman, A. F., & Steinwachs, D. M. (2003). Evidence-based psychosocial treatment practices in schizophrenia: Lessons from the Patient Outcomes Research Team (PORT) project. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry, 31, 141–154.
   PubMedGoogle Scholar
• Leucht, S., & Heres, S. (2006). Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. Journal of Clinical Psychiatry, 67(5), 3–8.
   PubMed Web of Science ®Google Scholar
• Marder, S. L., & Kane, J. M. (2005). Optimizing pharmacotherapy to maximize outcome in schizophrenia: Optimizing the long-term effectiveness of antipsychotic therapy. Journal of Clinical Psychiatry, 66, 123–125.
   Google Scholar
• Okuno, J., Yanagi, H., & Tomura, S. (2001). Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? European Journal of Clinical Pharmacology, 57(8), 589–594.
   PubMed Web of Science ®Google Scholar
• Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487–497.
   PubMed Web of Science ®Google Scholar
• Perkins, D. O., Gu, H., Weiden, P. J., McEvoy, J. P., Hamer, R. M., & Lieberman, J. A. (2008). Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. Journal of Clinical Psychiatry, 69(1), 106–113.
   PubMed Web of Science ®Google Scholar
• Perlick, D. A., Rosenheck, R. A., Kacynski, R., & Kozma, L. (2004). Medication nonadherence in bipolar disorder: A patient-centered review of research findings. Clinical Approaches in Bipolar Disorders, 3(2), 54–56.
   Google Scholar
• Rettenbacher, M., Hofer, A., Eder, U., Hummer, M., Kemmler, G., Weiss, E. M., & Fleischhacker, W. W. (2004). Compliance in schizophrenia: Psychopathology, side effects, and patient's attitudes toward the illness and medication. Journal of Clinical Psychiatry, 65(9), 1211–1218.
   PubMed Web of Science ®Google Scholar
• Sajatovic, M., Velligan, D. I., Weiden, P. J., Valenstein, M. A., & Ogedegbe, G. (2010). Measurement of psychiatric treatment adherence. Journal of Psychosomatic Research, 69(6), 591–599.
   PubMed Web of Science ®Google Scholar
• Velligan, D. I., Lam, F. L., Ereshefsky, L., & Miller, A. L. (2003). Perspectives on medication adherence and atypical antipsychotic medications. Psychiatric Services, 54, 665–667.
   PubMed Web of Science ®Google Scholar
• Weiden, P. J., & Olfson, M. (1995). Cost of relapse in schizophrenia. Schizophrenia Bulletin, 21, 419–429.
   PubMed Web of Science ®Google Scholar